Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

A randomised control trial of structured interrupted generic antiretroviral therapy versus continuous therapy in HIV-infected individuals in Southern India.

A randomised control trial of structured interrupted generic antiretroviral therapy versus continuous therapy in HIV-infected individuals in Southern India. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • A randomised control trial of structured interrupted generic antiretroviral therapy versus continuous therapy in HIV-infected individuals in Southern India. Abstract Text:

    n kumarasamyN Kumarasamy,t p flaniganT P Flanigan,s vallabhaneniS Vallabhaneni,a j ceceliaA J Cecelia,p christybaiP Christybai,p balakrishnanP Balakrishnan,t yepthomiT Yepthomi,s solomonS Solomon,c c j carpenterC C J Carpenter,k h mayerK H Mayer,

    This randomised control trial, conducted in Chennai, India, compared structured interrupted therapy (SIT) and continuous therapy (CT) in relation to immunologic and virologic outcomes, adverse events (AEs) and cost of therapy. ART-naïve adult HIV1-infected participants with CD4 counts 50-350 cells/mm(3), and plasma viral load (PVL)>5000 copies/mL were enrolled and placed on Indian-manufactured generic ART: zidovudine(AZT)/stavudine(d4T)+lamivudine(3TC)+efavirenz(EFV). After at least six months of continuous therapy, subjects were randomised to SIT (one-week-on/one-week-off cycles) or CT. The primary end-point was the proportion of subjects maintaining CD4>200 cells/mm(3) at six and 12 months after randomisation. Secondary end-points were effective viral suppression (PVL<400 copies/mL), AEs and cost. All analyses used intention-to-treat methodology. Of 40 participants (69% male; mean age 36+/-7; median baseline CD4 and PVL: 162 cell/mm(3)and 259,000 copies/mL), 17 were randomised to SIT and 18 to CT. At randomisation, median CD4s for SIT and CT were 378 cells/mm(3) and 357 cells/mm(3), respectively. All participants had PVL<400 copies/mL at time of randomisation. Median CD4 six months after randomisation was 498 cells/mm(3) and 417 cells/mm(3) for SIT and CT respectively. All participants had CD4>200 cells/mm(3). One participant on CT and two on SIT had sustained PVL>400 copies/mL. There were no serious AEs or deaths. Structured interrupted therapy cost was half of CT. Structured interrupted therapy was effective at maintaining CD4 above 200 cells/mm(3). Adverse events were comparable in both groups, with 50% reduction in cost for SIT. Further research on such strategies may benefit resource-constrained settings.

    A randomised control trial of structured interrupted generic antiretroviral therapy versus continuous therapy in HIV-infected individuals in Southern India. Publishing Authors By Initials

    n kumarasamyN Kumarasamy,tp flaniganTP Flanigan,s vallabhaneniS Vallabhaneni,aj ceceliaAJ Cecelia,p christybaiP Christybai,p balakrishnanP Balakrishnan,t yepthomiT Yepthomi,s solomonS Solomon,cc carpenterCC Carpenter,kh mayerKH Mayer,

    For similar investigative techniques: epidemiologic methods: epidemiologic study characteristics as topic: pilot projects research abstracts see: investigative techniques: epidemiologic methods: epidemiologic study characteristics as topic: pilot projects research

    PUBMED ID PMID:

    MEDLINE DATE:

    A randomised control trial of structured interrupted generic antiretroviral therapy versus continuous therapy in HIV-infected individuals in Southern India. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: AIDS care

    VOLUME: 19

    Page Numbers: 507-13

    Journal Abbreviation:

    ISSN: 0954-0121

    DAY: 3

    MONTH: Apr

    YEAR: 2007

    A randomised control trial of structured interrupted generic antiretroviral therapy versus continuous therapy in HIV-infected individuals in Southern India. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 8915313

    A randomised control trial of structured interrupted generic antiretroviral therapy versus continuous therapy in HIV-infected individuals in Southern India. Keywords Mesh Terms:

    KEYWORDS: Pilot Projects

    MESH TERMS: epidemiology

    Chemical & Substance for Abstract: A randomised control trial of structured interrupted generic antiretroviral therapy versus continuous therapy in HIV-infected individuals in Southern India. Information

    Substance Name: Drugs, Generic

    Registry Number: 0

    Grant and Affiliation Information for A randomised control trial of structured interrupted generic antiretroviral therapy versus continuous therapy in HIV-infected individuals in Southern India.

    AFFILIATION: YRG Center for AIDS Research and Education, VHS, Chennai, India. kumarasamy@yrgcare.org

    Country: England

    England Research PublicationEngland Research Publication

    AGENCY: United States NIAID

    GRANT: P30 AI42853

    ACRONYM: AI

    MEDLINETA: AIDS Care

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    A randomised control trial of structured interrupted generic antiretroviral therapy versus continuous therapy in HIV-infected individuals in Southern India Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News